6-Mar-2026
What's Going On With Anavex Life Sciences Stock On Wednesday?
Benzinga (Wed, 4-Mar 1:32 PM ET)
Anavex Life Sciences to Present at the Citizens Life Sciences Conference
Globe Newswire (Tue, 3-Mar 7:30 AM ET)
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference
Globe Newswire (Wed, 25-Feb 7:30 AM ET)
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Globe Newswire (Mon, 23-Feb 7:30 AM ET)
Globe Newswire (Mon, 9-Feb 7:30 AM ET)
Globe Newswire (Tue, 3-Feb 7:30 AM ET)
Globe Newswire (Tue, 13-Jan 7:30 AM ET)
PRNewswire (Thu, 8-Jan 8:13 PM ET)
PRNewswire (Thu, 8-Jan 10:00 AM ET)
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
Globe Newswire (Thu, 8-Jan 7:30 AM ET)
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Anavex Life Sciences Corp. trades on the NASDAQ stock market under the symbol AVXL.
As of March 6, 2026, AVXL stock price declined to $4.65 with 1,150,955 million shares trading.
AVXL has a beta of 1.11, meaning it tends to be more sensitive to market movements. AVXL has a correlation of 0.04 to the broad based SPY ETF.
AVXL has a market cap of $430.92 million. This is considered a Small Cap stock.
In the last 3 years, AVXL traded as high as $14.44 and as low as $2.86.
The top ETF exchange traded funds that AVXL belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
AVXL has underperformed the market in the last year with a return of -45.9%, while SPY returned +18.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AVXL shares. However, AVXL has outperformed the market in the last 3 month and 2 week periods, returning +5.7% and +12.9%, while SPY returned -1.7% and -2.5%, respectively. This indicates AVXL has been having a stronger performance recently.
AVXL support price is $4.54 and resistance is $4.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVXL shares will trade within this expected range on the day.